Evidence map›Paper›PMID 29688389›Full record

ArticleThe international journal of neuropsychopharmacology2018

Modulation of GSK-3β/β-Catenin Signaling Contributes to Learning and Memory Impairment in a Rat Model of Depression.

Jiaojie Hui, Jianping Zhang, Mengjia Pu, Xingliang Zhou, Liang Dong, Xuqiang Mao, Guofeng Shi, Jian Zou, Jingjing Wu, Dongmei Jiang and 1 more

Open access · goldAbstract read
In one paragraph

Article in The international journal of neuropsychopharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Glycogen synthase kinase-3 signaling in Alzheimer's disease.Biochimica et biophysica acta. Molecular cell research · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Jiaojie HuiDepartment of Critical Care Medicine, Wuxi, China.
Jianping ZhangDepartment of Neurology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, China.
Mengjia PuDepartment of Neurology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, China.
Xingliang ZhouEli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC, Department of Cell and Neurobiology, University of Southern California, Los Angeles, California.
Liang DongDepartment of Critical Care Medicine, Wuxi, China.
Xuqiang MaoDepartment of Neurology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, China.
Guofeng ShiDepartment of Neurology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, China.
Jian ZouDepartment of Clinical Laboratory Science, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, China.
Jingjing WuDepartment of Neurology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, China.
Dongmei JiangDepartment of Neurology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, China.
Guangjun XiDepartment of Neurology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, China.
Wuxi People's Hospital · CNNanjing Medical University · CNBroad Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: It is widely accepted that cognitive processes, such as learning and memory, are affected in depression, but the molecular mechanisms underlying the interactions of these 2 disorders are not clearly understood. Recently, glycogen synthase kinase-3 beta (GSK-3β)/β-catenin signaling was shown to play an important role in the regulation of learning and memory. Methods: The present study used a rat model of depression, chronic unpredictable stress, to determine whether hippocampal GSK-3β/β-catenin signaling was involved in learning and memory alterations. Results: Our results demonstrated that chronic unpredictable stress had a dramatic influence on spatial cognitive performance in the Morris water maze task and reduced the phosphorylation of Ser9 of GSK-3β as well as the total and nuclear levels of β-catenin in the hippocampus. Inhibition of GSK3β by SB216763 significantly ameliorated the cognitive deficits induced by chronic unpredictable stress, while overexpression of GSK3β by AAV-mediated gene transfer significantly decreased cognitive performance in adult rats. In addition, chronic unpredictable stress exposure increased the expression of the canonical Wnt antagonist Dkk-1. Furthermore, chronic administration of corticosterone significantly increased Dkk-1 expression, decreased the phosphorylation of Ser9 of GSK-3β, and resulted in the impairment of hippocampal learning and memory. Conclusions: Our results indicate that impairment of learning and memory in response to chronic unpredictable stress may be attributed to the dysfunction of GSK-3β/β-catenin signaling mediated by increased glucocorticoid signaling via Dkk-1.

Indexed as

Animalsbeta CateninCognitive DysfunctionCorticosteroneDepressive DisorderDisease Models, AnimalGene Transfer TechniquesGlycogen Synthase Kinase 3 betaHippocampusIndolesIntercellular Signaling Peptides and ProteinsLearning DisabilitiesMaleMaleimidesMaze LearningMemory Disordersbeta CateninCorticosteroneCtnnb1 protein, ratDkk1 protein, ratGlycogen Synthase Kinase 3 betaGsk3b protein, ratIndolesIntercellular Signaling Peptides and ProteinsMaleimidesNootropic AgentsSB 216763

Identifiers

PMID29688389
PMCPMC6119296
OpenAlexW2801664278

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.